ARAF Antikörper (AA 371-524)
Kurzübersicht für ARAF Antikörper (AA 371-524) (ABIN1886414)
Target
Alle ARAF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 371-524
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 371 and 524 of ARAF
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ARAF (V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF))
-
Andere Bezeichnung
- ARAF
-
Hintergrund
-
This proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development.[provided by RefSeq]
-
Molekulargewicht
- 68 kDa
-
Gen-ID
- 369
-
NCBI Accession
- NM_001654, NP_001645
-
Pathways
- MAPK Signalweg, RTK Signalweg, Hepatitis C
Target
-